Join to View Full Profile
Bldg 10 RM 6n110National Institutes of Health 9000 Rockville PikeBethesda, MD 20892
Phone+1 301-402-1541
Fax+1 301-480-5955
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Trials
- Body Composition Sub-study of the D2EFT Trial Start of enrollment: 2019 Dec 05
- Inflammation and Co-Infections in D²EFT Start of enrollment: 2021 Feb 01
Publications & Presentations
PubMed
- 3 citationsSequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infect...Vickie A Marshall, Elena M Cornejo Castro, Charles A Goodman, Nazzarena Labo, Isabella Liu
Plos Pathogens. 2024-07-01 - 27 citationsSafety, activity, and long-term outcomes of pomalidomide in the treatment of Kaposi sarcoma among individuals with or without HIV infection.Ramya Ramaswami, Mark N. Polizzotto, Kathryn Lurain, Kathleen M. Wyvill, Anaida Widell
Clinical Cancer Research. 2021-12-03 - 54 citationsHIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.Nila J. Dharan, Paul Yeh, Mark Bloch, Miriam M. Yeung, David Baker
Nature Medicine. 2021-06-01
Press Mentions
COVID Booster: Mixing and Matching Boosters, Delayed Surgery, and Testing Recalcitrant ChildrenJanuary 29th, 2022- IV Hyperimmune Immunoglobulin No Help in Severe COVIDJanuary 28th, 2022
- International Trial Uncovers Crucial Gaps in Our Understanding of Influenza TherapiesNovember 27th, 2020
- Join now to see all
